West Pharmaceutical Services, Inc. WST

370.44 (3.16) (0.85%) as of 25 Sep
Market cap
$26.3B
P/E
47.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

West Pharmaceutical Services, Inc. (WST) P/S ratio

As of 25 September 2026, West Pharmaceutical Services, Inc. (WST) trades at a P/S ratio of 7.9×. Over the past ten years it has ranged from 2.5× (February 2015) to 13.7× (September 2021); the current reading is higher than 67% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 6.5× (21.71%)
FY2024 8.3× (5.90%)
FY2023 8.8× 45.39%
FY2022 6.0× (50.98%)
FY2021 12.3× 26.37%
FY2020 9.8× 61.29%
FY2019 6.0× 43.34%
FY2018 4.2× (8.26%)
FY2017 4.6× 12.61%
FY2016 4.1× 31.83%

Quarterly

Period P/S ratio Change
Jun 2026 7.6× 36.37%
Mar 2026 5.6× (13.42%)
Dec 2025 6.5× 3.11%
Sep 2025 6.3× 17.60%
42 more quarters

Against its own ten years

Low 2.5× High 13.7×
Ten-year median 6.1×
Current reading's percentile 67

P/S ratio against peers

Company P/S ratio
MDLN Medline Inc. compare 1.0×
BAX Baxter International Inc. compare 1.1×
SOLV Solventum Corporation compare 1.9×
BDX Becton, Dickinson and Company compare 2.3×
COO The Cooper Companies, Inc. compare 2.5×
ALC Alcon compare 2.9×
RMD ResMed Inc. compare 5.7×
WST West Pharmaceutical Services, Inc. 7.9×
RGEN Repligen Corporation compare 13.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on WST